Patent · US Active

Octahydro fused azadecalin glucocorticoid receptor modulators

US10787449B2 · kind B2 · utility

11Cited by
18References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2019
Grant dateSep 29, 2020
Priority date
Expiry dateApr 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.